Russell Investments Group Ltd. Increases Stock Holdings in GoHealth, Inc. $GOCO

Russell Investments Group Ltd. increased its holdings in GoHealth, Inc. (NASDAQ:GOCOFree Report) by 77.3% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 37,366 shares of the company’s stock after purchasing an additional 16,290 shares during the period. Russell Investments Group Ltd. owned 0.16% of GoHealth worth $458,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. FNY Investment Advisers LLC purchased a new stake in shares of GoHealth in the first quarter valued at $31,000. Cubist Systematic Strategies LLC purchased a new stake in GoHealth during the fourth quarter valued at about $37,000. Wells Fargo & Company MN grew its position in GoHealth by 28.2% during the fourth quarter. Wells Fargo & Company MN now owns 2,760 shares of the company’s stock valued at $37,000 after acquiring an additional 607 shares during the period. N.E.W. Advisory Services LLC purchased a new stake in GoHealth during the first quarter valued at about $45,000. Finally, Bank of America Corp DE grew its position in GoHealth by 22.8% during the fourth quarter. Bank of America Corp DE now owns 7,831 shares of the company’s stock valued at $105,000 after acquiring an additional 1,452 shares during the period. Hedge funds and other institutional investors own 24.21% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on the company. Royal Bank Of Canada lowered their price target on GoHealth from $18.00 to $12.00 and set a “sector perform” rating for the company in a research report on Thursday. Wall Street Zen downgraded GoHealth from a “hold” rating to a “sell” rating in a research report on Friday, July 18th. Finally, Noble Financial reissued an “outperform” rating on shares of GoHealth in a research report on Friday, August 8th. One investment analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $12.00.

Get Our Latest Research Report on GOCO

GoHealth Trading Up 0.4%

Shares of GOCO opened at $5.11 on Monday. The stock’s 50-day moving average is $5.79 and its two-hundred day moving average is $8.88. The stock has a market cap of $146.20 million, a PE ratio of -1.42 and a beta of 1.62. GoHealth, Inc. has a 12 month low of $5.01 and a 12 month high of $21.00. The company has a debt-to-equity ratio of 2.64, a current ratio of 1.56 and a quick ratio of 1.56.

GoHealth (NASDAQ:GOCOGet Free Report) last issued its quarterly earnings data on Thursday, August 7th. The company reported ($1.23) EPS for the quarter, topping analysts’ consensus estimates of ($2.60) by $1.37. The company had revenue of $94.05 million for the quarter, compared to analysts’ expectations of $119.76 million. GoHealth had a negative return on equity of 8.74% and a negative net margin of 3.21%. Equities analysts forecast that GoHealth, Inc. will post -5.5 earnings per share for the current fiscal year.

About GoHealth

(Free Report)

GoHealth, Inc operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs.

See Also

Want to see what other hedge funds are holding GOCO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GoHealth, Inc. (NASDAQ:GOCOFree Report).

Institutional Ownership by Quarter for GoHealth (NASDAQ:GOCO)

Receive News & Ratings for GoHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GoHealth and related companies with MarketBeat.com's FREE daily email newsletter.